AnalystsInsight

David Coleman (Argus Research): Analyst Track Record and Price‑Target Accuracy

How often David Coleman’s price targets were reached, how fast, and what the stocks did after each call: a 7‑year backtest of 137 ratings, compared with the average Wall Street analyst.

Published Updated 3 min readHow we research

Key takeaways

  • David Coleman ranks #918 of 1,121 analysts in Exent’s scoring (4.6★).
  • 42.1% of price targets were reached over 7 years, versus 53.6% for the average analyst.
  • Median time to reach a target: 178 days; 62.1% of calls were up 12 months later.
  • Most‑covered stocks: AA, NUE, PKG, HOG.
  • Free on Exent: David Coleman’s full record, with ratings 3 days after publication.

David Coleman’s track record at a glance

David Coleman of Argus Research ranks #918 of the 1,121 analysts Exent scores, with a 4.6★ rating and a focus on materials. Over a 7‑year lookback, 42.1% of David’s price targets were reached, 11.5 points below the 53.6% average across all analysts.

MetricDavid ColemanAll analysts
Price‑target hit rate42.1%53.6%
Median days to hit target178 days91 days
Calls up after 12 months62.1%64.6%
Median 12‑month return of calls+7.8%+13.4%
Hit rate, last 2 years0.0%—
Average worst drop after a call−18.8%—
Ratings in the sample137—
Stocks covered38—

The full records of Exent’s top 90 analysts and the top 50 of each sector, and the stocks where several of them agree right now, are members‑only in Exent Gems.

How fast price targets were reached

Time to reach the targetDavid Coleman
Under 30 days6.7%
30–90 days17.8%
90–180 days26.7%
Over 180 days48.9%

Share of the targets that were reached, by how long they took. Targets are usually set for 12 months.

Stocks David Coleman covers most

StockRatings in the sample
AA13
NUE12
PKG12
HOG12
VMC11
GT9
THRM8
SON8

David Coleman’s latest ratings

DateStockActionRatingPrice target
Apr 28, 2025EFXReiterated: HoldHold$0.00
Feb 28, 2025SPHReiterated: BuyBuy$22.00
Feb 18, 2025GTUpgraded: BuyBuy$0.00
Feb 11, 2025EFXDowngraded: HoldHold$0.00
Oct 31, 2024WMReiterated: BuyBuy$240.00
Jun 12, 2024THOReiterated: HoldHold$0.00
May 9, 2024CMSReiterated: BuyBuy$70.00
Apr 25, 2024FCXReiterated: BuyBuy$54.00
Apr 22, 2024MANReiterated: HoldHold$0.00
Mar 5, 2024PMDowngraded: HoldHold$0.00
Feb 27, 2024WMReiterated: BuyBuy$230.00
Feb 26, 2024IPDowngraded: HoldHold$0.00
  • Apr 28, 2025
    Stock
    EFX
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $0.00
  • Feb 28, 2025
    Stock
    SPH
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $22.00
  • Feb 18, 2025
    Stock
    GT
    Action
    Upgraded: Buy
    Rating
    Buy
    Price target
    $0.00
  • Feb 11, 2025
    Stock
    EFX
    Action
    Downgraded: Hold
    Rating
    Hold
    Price target
    $0.00
  • Oct 31, 2024
    Stock
    WM
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $240.00
  • Jun 12, 2024
    Stock
    THO
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $0.00
  • May 9, 2024
    Stock
    CMS
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $70.00
  • Apr 25, 2024
    Stock
    FCX
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $54.00
  • Apr 22, 2024
    Stock
    MAN
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $0.00
  • Mar 5, 2024
    Stock
    PM
    Action
    Downgraded: Hold
    Rating
    Hold
    Price target
    $0.00
  • Feb 27, 2024
    Stock
    WM
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $230.00
  • Feb 26, 2024
    Stock
    IP
    Action
    Downgraded: Hold
    Rating
    Hold
    Price target
    $0.00

David’s ratings are free on Exent 3 days after publication. Exent Gems has them the same day, with the calls of the top‑ranked analysts and the stocks where several of them agree.

How Exent scores analysts

Exent replays every rating with a price target over a 7‑year lookback: was the target reached, how long it took, and what the stock returned 1, 3, 6 and 12 months after the call. The star rating and rank combine success rate, average return and the number of ratings, so a few lucky calls do not make a top analyst. Statistics as of Oct 20, 2026; ranking updated Oct 21, 2026. How accurate are analyst price targets overall?

Past performance does not guarantee future results. Historical figures are calculated by Exent from market data and are for education only; they are not investment advice or a recommendation to buy or sell any security.

Follow the analysts with the best records

  1. Exent Gems shows David Coleman’s live ratings and those of the top‑ranked analysts, without the 30‑day delay used on this page.
  2. Gems are the stocks where several 4★+ analysts agree: Exent’s shortlist of high‑conviction ideas.
  3. Check any idea against your own portfolio: correlation, concentration and crash exposure before you buy.

Exent is our product. Educational content, not investment advice.

Frequently asked questions

By Exent’s scoring David Coleman ranks #918 of 1,121 with a 4.6★ rating. 42.1% of price targets were reached over a 7-year lookback (all analysts: 53.6%), and 62.1% of calls were up 12 months later. Past accuracy does not guarantee future accuracy.

David Coleman’s success rate is 61.5% by the ranking source and 42.1% by Exent’s price-target hit-rate backtest, with a median of 178 days to reach a target.

David Coleman (Argus Research) covers 38 stocks, mostly in materials. The most frequently rated are AA, NUE, PKG, HOG, VMC.

Get the picks Wall Street’s best analysts agree on.

Exent tracks 4,000+ analysts, keeps only the elite few with proven records, and surfaces the Gems where they agree.

See this week’s GemsLimited offer$1.95 for full access· full access

Educational content, not investment advice. Examples are illustrative; past performance does not guarantee future results.

DISCLAIMER: Exent AI is an informational research platform and does not provide investment advice, financial advice, or act as an investment adviser, broker-dealer, or fiduciary. All content, analytics, and model outputs are provided for educational and informational purposes only and should not be relied upon as a recommendation to buy, sell, or hold any financial instrument. Investing involves risk, including the possible loss of principal. Exent AI does not execute trades, hold customer funds, or provide brokerage services. Past performance and hypothetical results are not indicative of future results. Third-party data and AI-generated outputs may be incomplete or inaccurate.